Literature DB >> 1325276

Primary intracranial germ cell tumor. Pathologic study of 51 patients.

D M Ho1, H C Liu.   

Abstract

Fifty-one primary intracranial germ cell tumors (GCT), including germinoma, teratoma, endodermal sinus tumor, choriocarcinoma and mixed GCT, were studied. The incidence of GCT in the surgically removed intracranial neoplasms was 11.1% for pediatric patients and 0.6% for adult patients. The age/sex of the patients and the location of the tumors were analyzed. Morphologic findings of these tumors were identical to that of their gonadal counterparts. Immunohistochemical studies showed that alpha-fetoprotein (alpha-AFP), human chorionic gonadotropin (HCG), and placental alkaline phosphatase (PLAP) were helpful, whereas carcinoembryonic antigen (CEA) and cytokeratin (CKER) were of little help in determining the diagnosis. Serum tumor markers, alpha-AFP and HCG, were helpful in recognizing GCT producing them. However, they could not be used for specific diagnosis because different tumors could have similar serum levels. Histopathologic study was handicapped by the small size of most specimens (which usually could not include all of the components if the tumor was a mixed GCT), but it was the only means for specific diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325276     DOI: 10.1002/1097-0142(19920915)70:6<1577::aid-cncr2820700622>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  A primary intrasellar mixed germ cell tumor with suprasellar extension.

Authors:  Joo Pyung Kim; Bong Jin Park; Young Jin Lim
Journal:  Childs Nerv Syst       Date:  2011-04-15       Impact factor: 1.475

Review 2.  Primary CNS germ cell tumors: current epidemiology and update on treatment.

Authors:  Jigisha P Thakkar; Lita Chew; J Lee Villano
Journal:  Med Oncol       Date:  2013-02-24       Impact factor: 3.064

3.  Intracranial germ-cell tumours--treatment results and residuals.

Authors:  C Haupt; U Ancker; M Muller; H D Herrmann; F J Schulte
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

4.  Treatment strategies for initially disseminated intracranial germinomas: experiences at a single institute.

Authors:  Yi-Wei Chen; Pin-I Huang; Yu-Wen Hu; Donald Ming-Tak Ho; Kai-Ping Chang; Wan-Yuo Guo; Feng-Chi Chang; Yi-Yen Lee; Cheng-Ying Shiau; Tai-Tong Wong; Sang-Hue Yen
Journal:  Childs Nerv Syst       Date:  2012-01-13       Impact factor: 1.475

5.  [The unmasking of secondary adrenal insufficiency and central diabetes insipidus by a highly febrile acute Hantaan virus infection].

Authors:  S Schröder; J Dilger; E M Weiss; F J Seif
Journal:  Med Klin (Munich)       Date:  1997-12-15

6.  Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors.

Authors:  M J Kang; S M Kim; Y A Lee; C H Shin; S W Yang; J S Lim
Journal:  Osteoporos Int       Date:  2011-11-05       Impact factor: 4.507

7.  HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma.

Authors:  Siyi Wanggou; Xingjun Jiang; Qiaoyu Li; Lihua Zhang; Dingyang Liu; Guifei Li; Xiangling Feng; Weidong Liu; Bin Zhu; Wei Huang; Jia Shi; Xianrui Yuan; Caiping Ren
Journal:  J Neurooncol       Date:  2011-08-23       Impact factor: 4.130

8.  Mixed germ cell tumors in septum pellucidum after radiochemotherapy of suprasellar germinoma: de novo metachronous or recurrent neoplasms?

Authors:  Ki Seong Eom; Jong Moon Kim; Tae Young Kim
Journal:  Childs Nerv Syst       Date:  2008-06-17       Impact factor: 1.475

9.  Extended focal radiotherapy of 30 Gy alone for intracranial synchronous bifocal germinoma: a single institute experience.

Authors:  Pin-I Huang; Yi-Wei Chen; Tai-Tong Wong; Yi-Yen Lee; Kai-Ping Chang; Wan-Yuo Guo; Feng-Chi Chang; Muh-Lii Liang; Hsin-Hung Chen; Shi-Hwa Chiou; Sang-Hue Yen
Journal:  Childs Nerv Syst       Date:  2008-06-25       Impact factor: 1.475

10.  Radiotherapy to primary CNS germinoma: how large an irradiated volume is justified for tumor control?

Authors:  Chen Kan Tseng; Ng Ming Tsang; Kuo Chen Wei; Tang Her Jaing; Ping Chin Pai; Tung Chieh Chang
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.